3,3'-Spiroindolinone Derivatives
    1.
    发明申请
    3,3'-Spiroindolinone Derivatives 失效
    3,3'-螺吲哚啉酮衍生物

    公开(公告)号:US20100273819A1

    公开(公告)日:2010-10-28

    申请号:US12748687

    申请日:2010-03-29

    CPC分类号: C07D471/10

    摘要: There are provided compounds of the formula or a pharmaceutically acceptable salt or ester thereof wherein X, Y, W, W′, V, V′, V″, R1, R2 and R3 are as herein described.The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 提供下式的化合物或其药学上可接受的盐或酯,其中X,Y,W,W',V,V',V“,R 1,R 2和R 3如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。

    3,3′-spiroindolinone derivatives
    3.
    发明授权
    3,3′-spiroindolinone derivatives 失效
    3,3'-螺茚啉酮衍生物

    公开(公告)号:US08076482B2

    公开(公告)日:2011-12-13

    申请号:US12748687

    申请日:2010-03-29

    IPC分类号: A61K31/438 C07D401/04

    CPC分类号: C07D471/10

    摘要: There are provided compounds of the formula or a pharmaceutically acceptable salt or ester thereof wherein X, Y, W, W′, V, V′, V″, R1, R2 and R3 are as herein described. The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 提供下式的化合物或其药学上可接受的盐或酯,其中X,Y,W,W',V,V',V“,R 1,R 2和R 3如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。

    SPIROINDOLINONE PYRIDINE DERIVATIVES
    4.
    发明申请
    SPIROINDOLINONE PYRIDINE DERIVATIVES 失效
    螺吲哚啉酮吡啶衍生物

    公开(公告)号:US20100204257A1

    公开(公告)日:2010-08-12

    申请号:US12685748

    申请日:2010-01-12

    CPC分类号: C07D471/10

    摘要: There are provided compounds of the formula or a pharmaceutically acceptable salt, ester or enantiomer thereof wherein W, X, Y, V, R1 and R2 are as described herein. The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 提供下式的化合物或其药学上可接受的盐,酯或对映异构体,其中W,X,Y,V,R 1和R 2如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。

    Spiroindolinone pyridine derivatives
    5.
    发明授权
    Spiroindolinone pyridine derivatives 失效
    螺吲哚啉酮吡啶衍生物

    公开(公告)号:US07928233B2

    公开(公告)日:2011-04-19

    申请号:US12685748

    申请日:2010-01-12

    IPC分类号: C07D401/04 A61K31/438

    CPC分类号: C07D471/10

    摘要: There are provided compounds of the formula or a pharmaceutically acceptable salt, ester or enantiomer thereof wherein W, X, Y, V, R1 and R2 are as described herein. The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 提供下式的化合物或其药学上可接受的盐,酯或对映异构体,其中W,X,Y,V,R 1和R 2如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。

    Spiroindolinone derivatives
    6.
    发明授权
    Spiroindolinone derivatives 失效
    螺吲哚啉酮衍生物

    公开(公告)号:US07776875B2

    公开(公告)日:2010-08-17

    申请号:US12273035

    申请日:2008-11-18

    IPC分类号: A61K31/438 C07D471/10

    CPC分类号: C07D471/10

    摘要: There are provided compounds of the formula and pharmaceutically acceptable salts and esters and enantiomers thereof wherein W, X, X′, Y, V, V′, A, B and R are as described herein. The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 提供下式的化合物及其药学上可接受的盐和酯和对映异构体,其中W,X,X',Y,V,V',A,B和R如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。

    Spiroindolinone Derivatives
    7.
    发明申请
    Spiroindolinone Derivatives 失效
    螺吲哚啉酮衍生物

    公开(公告)号:US20090163512A1

    公开(公告)日:2009-06-25

    申请号:US12273035

    申请日:2008-11-18

    CPC分类号: C07D471/10

    摘要: There are provided compounds of the formula and pharmaceutically acceptable salts and esters and enantiomers thereof wherein W, X, X′, Y, V, V′, A, B and R are as described herein.The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 提供下式的化合物及其药学上可接受的盐和酯和对映异构体,其中W,X,X',Y,V,V',A,B和R如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。

    Spiroindolinone derivatives
    9.
    发明授权
    Spiroindolinone derivatives 失效
    螺吲哚啉酮衍生物

    公开(公告)号:US07495007B2

    公开(公告)日:2009-02-24

    申请号:US11846597

    申请日:2007-08-29

    IPC分类号: A61K31/438 C07D471/10

    CPC分类号: C07D471/10

    摘要: The present invention relates to spiroindolinone derivatives of the formula and their enantiomers and pharmaceutically acceptable salts and esters thereof wherein R1, R2, R3, R4, R5, R6, R7 and R8, are as herein described. The compounds have utility as antiproliferative agents, especially, as anticancer agents.

    摘要翻译: 本发明涉及下式的螺二吲哚啉酮衍生物及其对映异构体及其药学上可接受的盐和酯,其中R 1,R 2,R 3,R 4,R 5,R 6,R 7和R 8如本文所述。 这些化合物具有抗增生剂的作用,特别是作为抗癌剂。